| Literature DB >> 33377056 |
Vittoria Matafora1, Angela Bachi1.
Abstract
Secretome analysis is crucial to unravel extracellular processes. However, secreted proteins are difficult to detect in mass-spectrometry-based analysis due to contamination of serum proteins deriving from cell culture media and to high glycosylation, which hampers tryptic digestion. Secret3D workflow is an optimized protocol for the global analysis of secretome from in vitro cultured cells. It allows efficient and robust protein identification and quantitation and provides information on putative N-glycosylation sites of the secreted proteins. For complete details on the use and execution of this protocol, please refer to Matafora et al. (2020).Entities:
Keywords: Cancer; Proteomics
Mesh:
Substances:
Year: 2020 PMID: 33377056 PMCID: PMC7757356 DOI: 10.1016/j.xpro.2020.100162
Source DB: PubMed Journal: STAR Protoc ISSN: 2666-1667
Figure 1Concentration and Buffer Exchange of Secreted Proteins
(A) Concentration of the cell culture medium. The solution in the lower part of the Falcon tube is discarded, while secreted proteins, present in the upper part, are concentrated to 500 μL.
(B) Further concentration of the secretome. The solution at the bottom of the tube is discarded, while secreted proteins, present in the upper part of the filter and indicated by the arrow, are concentrated to 30 μL.
Figure 2TIC (Upper Panel) and Base Peak Chromatogram (Lower Panel) of a Typical Secretome MS Analysis
Example of Quantitation and Analysis of the Top 50 Proteins Identified by Secret3D in IGR37 Cells (Heavy Labeled) and IGR39cells (Medium Labeled)
| Protein ID | Protein Name | Gene Name | Intensity Ratio H/M | Count Ratio H/M | Intensity M | Intensity H |
|---|---|---|---|---|---|---|
| apolipoprotein E | APOE | 2.80E+04 | 178 | 5.83E+09 | 6.45E+11 | |
| galectin-3-binding protein | LGALS3BP | 2.30E+00 | 53 | 2.22E+11 | 2.83E+11 | |
| P07093-2 | glia-derived nexin | SERPINE2 | 2.30E+00 | 30 | 1.83E+11 | 1.91E+11 |
| laminin subunit γ-1 | LAMC1 | 1.10E+00 | 43 | 2.02E+11 | 1.38E+11 | |
| vimentin | VIM | 1.10E+00 | 52 | 2.63E+11 | 1.22E+11 | |
| calumenin | CALU | 1.60E+00 | 48 | 1.56E+11 | 1.21E+11 | |
| procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 | PLOD3 | 3.00E+00 | 53 | 8.55E+10 | 1.16E+11 | |
| C9J2H1 | inter-α-trypsin inhibitor heavy chain H5 | ITIH5 | 9.00E+00 | 27 | 3.25E+10 | 1.12E+11 |
| G3XAI2 | laminin subunit β-1 | LAMB1 | 1.20E+00 | 70 | 1.48E+11 | 9.18E+10 |
| hemicentin-1 | HMCN1 | 1.70E+00 | 9 | 9.24E+10 | 9.12E+10 | |
| P10451-4 | osteopontin | SPP1 | 7.20E+00 | 10 | 3.17E+10 | 9.08E+10 |
| Protein disulfide-isomerase | P4HB | 1.20E+00 | 78 | 1.55E+11 | 8.57E+10 | |
| A0A0A0MTC7 | laminin subunit α-4 | LAMA4 | 1.00E+00 | 19 | 1.50E+11 | 8.46E+10 |
| histone H4 | HIST1H4A | 3.80E+01 | 23 | 3.27E+09 | 7.89E+10 | |
| α-enolase | ENO1 | 1.50E+00 | 50 | 1.42E+11 | 7.85E+10 | |
| actin, cytoplasmic 1 | ACTB | 1.10E+00 | 97 | 1.96E+11 | 7.85E+10 | |
| tenascin | TNC | 7.60E-01 | 61 | 1.84E+11 | 7.65E+10 | |
| chondroitin sulfate proteoglycan 4 | CSPG4 | 3.10E+00 | 67 | 4.17E+10 | 7.17E+10 | |
| serotransferrin | TF | 1.40E+01 | 22 | 7.38E+09 | 7.16E+10 | |
| U3KQK0 | histone H2B | HIST1H2BN | 3.40E+01 | 17 | 3.16E+09 | 7.08E+10 |
| A0A087WTA8 | collagen α-2(I) chain | COL1A2 | 2.70E+01 | 9 | 7.01E+09 | 6.57E+10 |
| P05067-11 | amyloid β A4 protein | APP | 1.60E+00 | 11 | 5.80E+10 | 6.44E+10 |
| 78 kDa glucose-regulated protein | HSPA5 | 9.40E-01 | 60 | 1.29E+11 | 6.03E+10 | |
| extracellular matrix protein 1 | ECM1 | 3.00E+00 | 10 | 3.19E+10 | 5.74E+10 | |
| protein disulfide-isomerase A3 | PDIA3 | 1.00E+00 | 65 | 1.17E+11 | 5.70E+10 | |
| J3KPS3 | fructose-bisphosphate aldolase A | ALDOA | 1.20E+00 | 39 | 1.12E+11 | 5.58E+10 |
| adipocyte enhancer-binding protein 1 | AEBP1 | 3.70E+00 | 11 | 2.56E+10 | 5.55E+10 | |
| L-lactate dehydrogenase A chain | LDHA | 8.20E-01 | 54 | 1.64E+11 | 5.45E+10 | |
| Thrombospondin-1 | THBS1 | 1.70E-01 | 49 | 5.50E+11 | 5.09E+10 | |
| basement membrane-specific heparan sulfate proteoglycan | HSPG2 | 1.60E+00 | 12 | 5.51E+10 | 5.01E+10 | |
| D3DQH8 | SPARC | SPARC | 8.40E-01 | 16 | 1.15E+11 | 4.93E+10 |
| α-2-macroglobulin | A2M | 3.50E-01 | 88 | 2.69E+11 | 4.87E+10 | |
| 14-3-3 protein epsilon | YWHAE | 9.20E-01 | 28 | 1.19E+11 | 4.72E+10 | |
| A0A087X0S5 | collagen α-1(VI) chain | COL6A1 | 3.40E-01 | 49 | 2.63E+11 | 4.38E+10 |
| A0A0A6YY95 | C-type lectin domain family 11 member A | CLEC11A | 1.20E+02 | 5 | 1.30E+09 | 4.31E+10 |
| moesin | MSN | 1.10E+00 | 34 | 7.93E+10 | 4.29E+10 | |
| calsyntenin-1 | CLSTN1 | 1.10E+00 | 10 | 6.47E+10 | 4.14E+10 | |
| glutaminyl-peptide cyclotransferase | QPCT | 1.30E+03 | 47 | 571420000 | 4.01E+10 | |
| K7EK07 | Histone H3 | H3F3B | 7.30E+01 | 12 | 1.79E+09 | 3.92E+10 |
| insulin-like growth factor-binding protein 2 | IGFBP2 | 1.50E+00 | 12 | 5.21E+10 | 3.89E+10 | |
| phosphoglycerate kinase 1 | PGK1 | 2.60E+00 | 30 | 3.54E+10 | 3.81E+10 | |
| heat shock protein HSP 90-alpha | HSP90AA1 | 9.40E-01 | 47 | 1.17E+11 | 3.76E+10 | |
| heat shock cognate 71 kDa protein | HSPA8 | 8.50E-01 | 56 | 9.86E+10 | 3.70E+10 | |
| protein disulfide-isomerase A4 | PDIA4 | 1.10E+00 | 40 | 6.33E+10 | 3.65E+10 | |
| growth/differentiation factor 15 | GDF15 | 1.50E+03 | 63 | 1.58E+09 | 3.41E+10 | |
| α-actinin-4 | ACTN4 | 5.30E-01 | 52 | 1.66E+11 | 3.41E+10 | |
| L-lactate dehydrogenase B chain | LDHB | 9.70E-01 | 40 | 8.36E+10 | 3.29E+10 | |
| P02545-2 | prelamin-A/C | LMNA | 3.30E-01 | 61 | 1.95E+11 | 3.11E+10 |
| lysyl oxidase homolog 4 | LOXL4 | 1.70E+00 | 4 | 2.75E+10 | 3.03E+10 |
Figure 3Subcellular Component Analysis of Secreted Proteins Identified by Secret3D Workflow
(A) Subcellular localization analysis performed by using the Compartments database.
(B) Venn diagram comparing the secreted proteins identified by Secret3D with the human cancer secretome database.
(C) Venn diagram comparing the secreted proteins identified by Secret3D and predicted secreted and transmembrane proteins in the Human Proteins Atlas Database.
Figure 4Analysis of Asn Deamidated Peptides in IGR37 versus IGR39 Cell Lines
Upper panel: Venn diagram indicating the modified peptides and total peptides identified. Lower panel: MS/MS spectrum of a tenascin glycosylated peptide.
Figure 5Sequence Coverage Analysis
Comparison of the sequence coverage of the proteins identified in IGR37 versus IGR39 cell lines by Secret3D or by a method without de-glycosylation and double digestion. t test: ∗∗∗∗p < 0.00001.
Figure 6Example of Volcano Plot Representation of Significantly Modulated Proteins (Red Dots)
Intensity Ratio H/L of the proteins identified in metastatic (H) versus primitive (L) melanoma cell lines and p values are reported in the graph. The analysis was performed on three biological replicates. t test analysis, FDR <0.05, was used to select significant proteins.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Heavy L-arginine-13C6,15N4 HCl | Isotec (Sigma) | Cat#608033-500 MG |
| Heavy L-lysine-13C6,15N2 2HCl | Cambridge Isotope Laboratories | Cat#CILCLM-291-0.25 |
| Medium L-arginine-13C6 HCl | Cambridge Isotope Laboratories | Cat#CILCLM-2265-05 |
| Medium L-lysine-4,4,5,5-D4 2HCl | Cambridge Isotope Laboratories | Cat#CILCLM-2640-0.5 |
| 2-Chloroacetamide | Sigma-Aldrich | Cat#C0267 |
| Ammonium bicarbonate | Sigma-Aldrich | Cat#09830 |
| Acetonitrile | Fisher Chemical | Cat#A955-4 |
| Formic acid | Fisher Chemical | Cat#A117-50 |
| Tris hydrochloride Tris-HCl | Sigma-Aldrich | Cat#10812846001 |
| Sodium chloride | Sigma-Aldrich | Cat#S7653-250G |
| Phosphate buffered saline PBS | Sigma-Aldrich | Cat#P5493 |
| TCEP | Thermo scientific | Cat#20490 |
| Buffer G | New England Biolabs | Cat#P0704S |
| PNGase F | New England Biolabs | Cat#P0704S |
| Trypsin, Sequencing Grade, modified | ROCHE | Cat#11 418 025 001 |
| Endoproteinase Glu-C Sequencing Grade | ROCHE | Cat#11420399001 |
| DMEM, high glucose, no glutamine, no lysine, no arginine | Thermo Fisher Scientific | Cat#A1443101 |
| RPMI Medium (lysine and arginine depleted) | Thermo Fisher Scientific | Cat#88365 |
| FBS Dialyzed USA Origin | Invitrogen | Cat#26400044 |
| Bradford | Applied Biosystems | Cat#4368814 |
| .RAW files were deposited together with all peptides identified and parameters used for the analysis | Peptide Atlas repository | |
| IGR37 | DSMZ | Cat#ACC-237 |
| IGR39 | DSMZ | Cat#ACC-239 |
| Microsoft Excel 2010 | Microsoft Office | N/A |
| MaxQuant | Max Planck Institute of Biochemistry | |
| Perseus | Max Planck Institute of Biochemistry | |